Loeillot Olivier
SEC CIK 1995525 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | Pres, CCO | 53.8K | — | $4.19M | 18 | 2023-10-02 | 2026-09-21 |
Most active insiders at RGEN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hunt Anthony | Dir | — | $7.01M |
| 2 | Loeillot Olivier | CEO, Dir | — | $4.19M |
| 3 | Bylund James | COO | — | $331.3K |
| 4 | Garland Jason K | CFO | — | $185.8K |
| 5 | DAWES KAREN A | Dir | — | $44.3K |
| 6 | Douglass Brian Robb | Chief PRODUCT Off | — | — |
| 7 | Pax Margaret | Dir | — | — |
| 8 | Hughes Violetta | CAO | — | — |
| 9 | Mhatre Rohin | Dir | — | — |
| 10 | Konstantinov Konstantin | Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-22 16:07 | 2026-09-21 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | M - OptEx | $141.79 | +5,426 | 53.8K | +11% | +$769.4K |
| DT | 2026-09-22 16:07 | 2026-09-21 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | S - Sale+OE | $180.00 | -5,426 | 48.4K | -10% | -$976.7K |
| T | 2026-09-08 16:13 | 2026-09-03 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | F - Tax | $169.61 | -2,842 | 51.4K | -5% | -$482.0K |
| T | 2026-09-08 16:13 | 2026-09-04 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | S - Sale | $165.90 | -3,035 | 48.4K | -6% | -$503.5K |
| DT | 2026-08-21 16:06 | 2026-08-20 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | M - OptEx | $141.79 | +5,426 | 59.7K | +10% | +$769.4K |
| DT | 2026-08-21 16:06 | 2026-08-20 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | S - Sale+OE | $180.00 | -5,426 | 54.2K | -9% | -$976.7K |
| T | 2026-04-22 13:26 | 2026-04-21 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | S - Sale | $140.00 | -3,832 | 54.2K | -7% | -$536.5K |
| D | 2026-03-23 | 2026-03-05 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO | A - Grant | $0.00 | +24.1K | 58.1K | +71% | $0 |
| M | 2026-03-03 | 2026-02-27+ | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | F - Tax | $125.63 | -1,954 | 35.6K | -5% | -$245.5K |
| T | 2025-11-26 | 2025-11-25 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | S - Sale | $170.00 | -7,041 | 35.9K | -16% | -$1.20M |
| 2025-10-06 | 2025-10-02 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | F - Tax | $145.23 | -1,248 | 42.9K | -3% | -$181.2K | |
| 2025-09-04 | 2025-09-03 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | F - Tax | $116.18 | -2,506 | 44.2K | -5% | -$291.1K | |
| D | 2025-03-04 | 2025-03-03 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | A - Grant | $0.00 | +14.5K | 46.7K | +45% | $0 |
| 2025-02-28 | 2025-02-27 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | F - Tax | $156.54 | -343 | 32.2K | -1% | -$53.7K | |
| 2024-11-21 | 2024-11-20 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | F - Tax | $123.41 | -861 | 32.6K | -3% | -$106.3K | |
| D | 2024-09-04 | 2024-09-03 | RGEN | REPLIGEN CORP | Loeillot Olivier | CEO, Dir | A - Grant | $0.00 | +17.6K | 33.4K | +112% | $0 |
| D | 2024-02-29 | 2024-02-27 | RGEN | REPLIGEN CORP | Loeillot Olivier | Pres, CCO | A - Grant | $0.00 | +2,880 | 15.8K | +22% | $0 |
| D | 2023-10-03 | 2023-10-02 | RGEN | REPLIGEN CORP | Loeillot Olivier | Pres, CCO | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations